149 related articles for article (PubMed ID: 12779122)
1. Transgenic and tissue culture analyses of the muscle creatine kinase enhancer Trex control element in skeletal and cardiac muscle indicate differences in gene expression between muscle types.
Nguyen QG; Buskin JN; Himeda CL; Fabre-Suver C; Hauschka SD
Transgenic Res; 2003 Jun; 12(3):337-49. PubMed ID: 12779122
[TBL] [Abstract][Full Text] [Related]
2. Quantitative proteomic identification of six4 as the trex-binding factor in the muscle creatine kinase enhancer.
Himeda CL; Ranish JA; Angello JC; Maire P; Aebersold R; Hauschka SD
Mol Cell Biol; 2004 Mar; 24(5):2132-43. PubMed ID: 14966291
[TBL] [Abstract][Full Text] [Related]
3. A novel site in the muscle creatine kinase enhancer is required for expression in skeletal but not cardiac muscle.
Fabre-Suver C; Hauschka SD
J Biol Chem; 1996 Mar; 271(9):4646-52. PubMed ID: 8617727
[TBL] [Abstract][Full Text] [Related]
4. E-box sites and a proximal regulatory region of the muscle creatine kinase gene differentially regulate expression in diverse skeletal muscles and cardiac muscle of transgenic mice.
Shield MA; Haugen HS; Clegg CH; Hauschka SD
Mol Cell Biol; 1996 Sep; 16(9):5058-68. PubMed ID: 8756664
[TBL] [Abstract][Full Text] [Related]
5. Differences in the function of three conserved E-boxes of the muscle creatine kinase gene in cultured myocytes and in transgenic mouse skeletal and cardiac muscle.
Nguyen QG; Buskin JN; Himeda CL; Shield MA; Hauschka SD
J Biol Chem; 2003 Nov; 278(47):46494-505. PubMed ID: 12968024
[TBL] [Abstract][Full Text] [Related]
6. Analysis of muscle creatine kinase gene regulatory elements in skeletal and cardiac muscles of transgenic mice.
Donoviel DB; Shield MA; Buskin JN; Haugen HS; Clegg CH; Hauschka SD
Mol Cell Biol; 1996 Apr; 16(4):1649-58. PubMed ID: 8657140
[TBL] [Abstract][Full Text] [Related]
7. Multiple regulatory elements contribute differentially to muscle creatine kinase enhancer activity in skeletal and cardiac muscle.
Amacher SL; Buskin JN; Hauschka SD
Mol Cell Biol; 1993 May; 13(5):2753-64. PubMed ID: 8474439
[TBL] [Abstract][Full Text] [Related]
8. Skeletal muscle properties in a transgenic mouse model for amyotrophic lateral sclerosis: effects of creatine treatment.
Derave W; Van Den Bosch L; Lemmens G; Eijnde BO; Robberecht W; Hespel P
Neurobiol Dis; 2003 Aug; 13(3):264-72. PubMed ID: 12901841
[TBL] [Abstract][Full Text] [Related]
9. Differential myogenicity of satellite cells isolated from extensor digitorum longus (EDL) and soleus rat muscles revealed in vitro.
Lagord C; Soulet L; Bonavaud S; Bassaglia Y; Rey C; Barlovatz-Meimon G; Gautron J; Martelly I
Cell Tissue Res; 1998 Mar; 291(3):455-68. PubMed ID: 9477302
[TBL] [Abstract][Full Text] [Related]
10. Muscle creatine kinase sequence elements regulating skeletal and cardiac muscle expression in transgenic mice.
Johnson JE; Wold BJ; Hauschka SD
Mol Cell Biol; 1989 Aug; 9(8):3393-9. PubMed ID: 2796990
[TBL] [Abstract][Full Text] [Related]
11. Mouse soleus (slow) muscle shows greater intramyocellular lipid droplet accumulation than EDL (fast) muscle: fiber type-specific analysis.
Komiya Y; Sawano S; Mashima D; Ichitsubo R; Nakamura M; Tatsumi R; Ikeuchi Y; Mizunoya W
J Muscle Res Cell Motil; 2017 Apr; 38(2):163-173. PubMed ID: 28281032
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres.
Lin J; Wu H; Tarr PT; Zhang CY; Wu Z; Boss O; Michael LF; Puigserver P; Isotani E; Olson EN; Lowell BB; Bassel-Duby R; Spiegelman BM
Nature; 2002 Aug; 418(6899):797-801. PubMed ID: 12181572
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of FGF receptors and of myogenic regulatory factors in primary cultures of satellite cells originating from fast (EDL) and slow (Soleus) twitch rat muscles.
Martelly I; Soulet L; Bonnavaud S; Cebrian J; Gautron J; Barritault D
Cell Mol Biol (Noisy-le-grand); 2000 Nov; 46(7):1239-48. PubMed ID: 11075953
[TBL] [Abstract][Full Text] [Related]
14. Expression of nitric oxide synthase in skeletal muscle: a novel role for nitric oxide as a modulator of insulin action.
Kapur S; Bédard S; Marcotte B; Côté CH; Marette A
Diabetes; 1997 Nov; 46(11):1691-700. PubMed ID: 9356014
[TBL] [Abstract][Full Text] [Related]
15. Expression of dystrophin driven by the 1.35-kb MCK promoter ameliorates muscular dystrophy in fast, but not in slow muscles of transgenic mdx mice.
Dunant P; Larochelle N; Thirion C; Stucka R; Ursu D; Petrof BJ; Wolf E; Lochmüller H
Mol Ther; 2003 Jul; 8(1):80-9. PubMed ID: 12842431
[TBL] [Abstract][Full Text] [Related]
16. Genetic architecture of fast- and slow-twitch skeletal muscle weight in 200-day-old mice of the C57BL/6J and DBA/2J lineage.
Lionikas A; Blizard DA; Vandenbergh DJ; Glover MG; Stout JT; Vogler GP; McClearn GE; Larsson L
Physiol Genomics; 2003 Dec; 16(1):141-52. PubMed ID: 14679300
[TBL] [Abstract][Full Text] [Related]
17. Use of DNA injection for identification of slow nerve-dependent regions of the MLC2s gene.
Lupa-Kimball VA; Esser KA
Am J Physiol; 1998 Jan; 274(1):C229-35. PubMed ID: 9458732
[TBL] [Abstract][Full Text] [Related]
18. Human cytomegalovirus IE1 promoter/enhancer drives variable gene expression in all fiber types in transgenic mouse skeletal muscle.
Hallauer PL; Hastings KE
BMC Genet; 2000; 1():1. PubMed ID: 11038264
[TBL] [Abstract][Full Text] [Related]
19. Muscle creatine kinase-deficient mice. II. Cardiac and skeletal muscles exhibit tissue-specific adaptation of the mitochondrial function.
Veksler VI; Kuznetsov AV; Anflous K; Mateo P; van Deursen J; Wieringa B; Ventura-Clapier R
J Biol Chem; 1995 Aug; 270(34):19921-9. PubMed ID: 7650007
[TBL] [Abstract][Full Text] [Related]
20. Proteomic analysis of slow- and fast-twitch skeletal muscles.
Okumura N; Hashida-Okumura A; Kita K; Matsubae M; Matsubara T; Takao T; Nagai K
Proteomics; 2005 Jul; 5(11):2896-906. PubMed ID: 15981298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
